Halozyme Therapeutics Market Sentiment

Halozyme Therapeutics Inc

HALONASDAQ

Trade with Public

$113.90

-1.32-1.15%

가까이에: Sep 25, 5:00 PM EST

$114.18

0.280.25%

시간외: 4:02 PM EST

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

Halozyme Therapeutics Market Sentiment

Market sentiment signals for Halozyme Therapeutics (HALO): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Market Outperform

Short Interest▼ 17.5% short float

Options Flow▲ 0.22 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Market Outperform

16 analysts

Options Flow (P/C)

0.22

More calls — Bullish

94 calls · 21 puts

Avg Consensus PT

$83

-27.7%

Highest Price Target

$115

+0.7%

HC Wainwright & Co.

Lowest Price Target

$47

-58.8%

Leerink Partners

Short Interest

17.5%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 2, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+0.7%	$115 → $115	Maintained	Buy
Aug 7, 2026	Leerink Partners	David Risinger—	-3.7%	$83 → $110	Upgrade	Market Perform→Outperform
Aug 7, 2026	TD Cowen	Brendan Smith—	-8.0%	$96 → $105	Maintained	Buy
Aug 7, 2026	Citizens	Jason N. Butler—	-18.5%	$92 → $93	Maintained	Market Outperform
Aug 7, 2026	Wells Fargo	Mohit Bansal—	-16.8%	$75 → $95	Maintained	Equal-Weight
Aug 7, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+0.7%	$95 → $115	Maintained	Buy
Jul 21, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	-16.8%	$95 → $95	Maintained	Buy
May 12, 2026	Morgan Stanley	Vikram Purohit—	-18.5%	$96 → $93	Maintained	Overweight
Apr 29, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	-16.8%	$90 → $95	Maintained	Buy
Feb 19, 2026	Benchmark	Robert Wasserman—	-21.2%	$75 → $90	Maintained	Buy
Feb 19, 2026	Wells Fargo	Mohit Bansal—	-34.3%	$65 → $75	Maintained	Equal-Weight
Jan 8, 2026	TD Cowen	Brendan Smith—	-21.2%	$79 → $90	Maintained	Buy
Dec 19, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	-21.2%	$90 → $90	Maintained	Buy
Nov 28, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	-21.2%	$90 → $90	Maintained	Buy
Nov 18, 2025	Goldman Sachs	Graig Suvannavejh—	-51.0%	$54 → $56	Maintained	Neutral
Nov 4, 2025	Citizens	Jason Butler—	-19.4%	$91 → $92	Maintained	Market Outperform
Oct 27, 2025	JP Morgan	Jessica Fye—	-43.1%	$63 → $65	Maintained	Neutral
Oct 20, 2025	Morgan Stanley	Vikram Purohit—	-30.8%	$80 → $79	Maintained	Overweight
Oct 15, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	-21.2%	$90 → $90	Maintained	Buy
Oct 14, 2025	Leerink Partners	David Risinger—	-38.7%	$70	Upgrade	Underperform→Market Perform
Oct 2, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	-21.2%	$85 → $90	Maintained	Buy
Sep 24, 2025	Benchmark	Robert Wasserman—	-21.2%	$75 → $90	Maintained	Buy
Sep 22, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	-25.6%	$75 → $85	Maintained	Buy
Aug 18, 2025	Morgan Stanley	Vikram Purohit—	-29.9%	$75 → $80	Maintained	Overweight
Aug 7, 2025	JP Morgan	Jessica Fye—	-44.8%	$60 → $63	Maintained	Neutral